François Spertini Selected Research

François Spertini Research Topics

Disease

10	Malaria 01/2020 - 11/2005
8	Asthma (Bronchial Asthma) 04/2020 - 11/2006
7	Infections 01/2020 - 09/2002
6	Hypersensitivity (Allergy) 04/2020 - 04/2003
4	Anaphylaxis (Anaphylactic Shock) 04/2017 - 09/2008
4	Tuberculosis (Tuberculoses) 01/2017 - 07/2014
4	Allergic Rhinitis 01/2016 - 04/2004
2	Fever (Fevers) 01/2018 - 02/2013
2	Giant Cell Arteritis (Horton Disease) 10/2017 - 01/2017
2	Vasculitis (Vasculitides) 01/2017 - 11/2005
2	Immune System Diseases (Immune Disorders) 10/2014 - 04/2009
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2013 - 01/2007
2	Inflammation (Inflammations) 01/2012 - 01/2011
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 04/2009 - 11/2005
1	Dengue (Dengue Fever) 12/2023
1	Severe Dengue 12/2023
1	Non-Muscle Invasive Bladder Neoplasms 01/2020
1	COVID-19 01/2020
1	Critical Illness (Critically Ill) 10/2019
1	Membranous Glomerulonephritis (Membranous Nephropathy) 10/2017
1	Eosinophilia 10/2017
1	Nephrotic Syndrome (Syndrome, Nephrotic) 10/2017
1	Glomerulonephritis 10/2017
1	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 10/2017
1	Blindness (Hysterical Blindness) 10/2017
1	Lymphadenopathy 10/2017
1	Communicable Diseases (Infectious Diseases) 04/2017
1	Adult-Onset Still's Disease 12/2016
1	Rheumatic Diseases (Rheumatism) 12/2016
1	Food Hypersensitivity (Food Allergy) 04/2016
1	HIV Infections (HIV Infection) 07/2014
1	Pruritus (Itching) 01/2014
1	Arthritis (Polyarthritis) 01/2012
1	Muscular Diseases (Myopathy) 04/2009
1	Mastocytosis 04/2009

Drug/Important Bio-Agent (IBA)

10	VaccinesIBA 12/2023 - 05/2005
9	AntigensIBA 01/2020 - 12/2005
8	AntibodiesIBA 12/2023 - 11/2005
7	AllergensIBA 04/2020 - 02/2009
7	Proteins (Proteins, Gene)FDA Link 10/2019 - 09/2002
5	SteroidsIBA 10/2017 - 01/2009
5	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2017 - 05/2009
4	Peptides (Polypeptides)IBA 12/2023 - 10/2009
3	Monoclonal AntibodiesIBA 01/2020 - 12/2004
3	Interleukin-10 (Interleukin 10)IBA 10/2019 - 01/2011
3	Immunoglobulin E (IgE)IBA 01/2019 - 06/2013
3	EpitopesIBA 12/2014 - 05/2003
2	Protein Subunit VaccinesIBA 12/2023 - 01/2019
2	Aluminum Hydroxide (Algeldrate)FDA Link 01/2020 - 01/2019
2	Azathioprine (Imuran)FDA LinkGeneric 01/2012 - 01/2007
2	Histamine Antagonists (Antihistamines)IBA 05/2009 - 04/2004
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 04/2009 - 11/2005
1	GoldIBA 12/2023
1	Dengue VaccinesIBA 12/2023
1	Neutralizing AntibodiesIBA 01/2020
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2020
1	CarbohydratesIBA 10/2019
1	Interleukin-6 (Interleukin 6)IBA 10/2019
1	Inflammation MediatorsIBA 01/2019
1	Rabies Vaccines (Rabies Vaccine)FDA Link 01/2019
1	LipidsIBA 01/2019
1	EmulsionsIBA 01/2019
1	C-Reactive ProteinIBA 01/2018
1	Antirheumatic Agents (DMARD)IBA 01/2018
1	Prednisone (Sone)FDA LinkGeneric 01/2018
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 10/2017
1	tocilizumab (atlizumab)FDA Link 10/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 10/2017
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2017
1	Estrogens (Estrogen)FDA Link 04/2017
1	mepolizumabIBA 01/2017
1	dupilumabIBA 01/2017
1	Interleukin-18 (Interleukin 18)IBA 12/2016
1	Tuberculosis VaccinesIBA 12/2015
1	BCG Vaccine FDA Link 12/2015
1	Interleukin-13IBA 01/2014
1	Interleukin-5 (Interleukin 5)IBA 01/2014
1	PowdersIBA 01/2014
1	InterferonsIBA 02/2013
1	Malaria VaccinesIBA 09/2011
1	Biomarkers (Surrogate Marker)IBA 04/2011
1	ProteomeIBA 04/2011
1	AerosolsIBA 01/2011
1	OvalbuminIBA 01/2011
1	Therapeutic UsesIBA 01/2011
1	mannide monooleateIBA 10/2009
1	Vasoconstrictor AgentsIBA 05/2009
1	Tryptases (Tryptase)IBA 04/2009
1	Antinuclear AntibodiesIBA 04/2009

Therapy/Procedure

7	Therapeutics 01/2020 - 11/2006
2	Immunotherapy 04/2020 - 02/2009
1	Intravesical Administration 01/2020
1	Parenteral Nutrition 10/2019
1	Enteral Nutrition (Feeding, Tube) 10/2019
1	Drug Therapy (Chemotherapy) 01/2016
1	Chemoprevention 12/2015
1	Biological Therapy 10/2014
1	Highly Active Antiretroviral Therapy (HAART) 07/2014
1	Intranasal Administration 01/2012
1	Secondary Prevention 04/2011